RBP4: A controversial adipokine

European Journal of Endocrinology

Volumn 165, Issue 5, 2011, Pages 703-711

  Kotnik, Primoz ^a,b   Fischer Posovszky, Pamela ^a   Wabitsch, Martin ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

FENRETINIDE; GLUCOSE TRANSPORTER 4; METFORMIN; PIOGLITAZONE; PREALBUMIN; RETINOL BINDING PROTEIN 4; ROSIGLITAZONE; TROGLITAZONE;

ADIPOSE TISSUE; BODY FAT DISTRIBUTION; EXERCISE; GENE; GENETIC ASSOCIATION; GLUCOSE INTOLERANCE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; IRON METABOLISM; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RETINOIC ACID BINDING PROTEIN 4 GENE; RETINOIC ACID GENE HOMOLOG 6; REVIEW; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT REDUCTION;

ADIPOKINES; ADIPOSE TISSUE; ANIMALS; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; OBESITY; RETINOL-BINDING PROTEINS, PLASMA;

EID: 80054801141     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0431     Document Type: Review

References (93)

1. Sen Y, Kandemir N, Alikasifoglu A, Gonc N & Ozon A. Prevalence and risk factors of metabolic syndrome in obese children and adolescents: the role of the severity of obesity. European Journal of Pediatrics 2008 167 1183-1189. (doi:10.1007/s00431-007- 0658-x)
2. D'Adamo E, Santoro N & Caprio S. Metabolic syndrome in pediatrics: old concepts revised, new concepts discussed. Endocrinology and Metabolism Clinics of North America 2009 38 549-563. (doi:10.1016/j.ecl.2009.06.002)
3. Ahima RS. Adipose tissue as an endocrine organ. Obesity 2006 14 (Suppl 5) 242S-249S. (doi:10.1038/oby.2006.317)
4. Kershaw EE & Flier JS. Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism 2004 89 2548-2556. (doi:10.1210/jc. 2004-0395)
5. Fischer-Posovszky P, Wabitsch M & Hochberg Z. Endocrinology of adipose tissue - an update. Hormone and Metabolic Research 2007 39 314-321. (doi:10.1055/s-2007-976539)
6. Esteve E, Ricart W & Fernandez-Real JM. Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin. Diabetes Care 2009 32 (Suppl 2) S362-S367. (doi:10.2337/dc09-S340)
7. Galic S, Oakhill JS & Steinberg GR. Adipose tissue as an endocrine organ. Molecular and Cellular Endocrinology 2010 316 129-139. (doi:10.1016/j.mce.2009.08.018)
8. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L & Kahn BB. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005 436 356-362. (doi:10.1038/nature03711)
9. Janke J, Engeli S, Boschmann M, Adams F, Bohnke J, Luft FC, Sharma AM & Jordan J. Retinol-binding protein 4 in human obesity. Diabetes 2006 55 2805-2810. (doi:10.2337/db06-0616)
10. Yao-Borengasser A, Varma V, Bodles AM, Rasouli N, Phanavanh B, Lee MJ, Starks T, Kern LM, Spencer HJ III, Rashidi AA, McGehee RE Jr, Fried SK & Kern PA. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. Journal of Clinical Endocrinology and Metabolism 2007 92 2590-2597. (doi:10. 1210/jc.2006-0816)
11. Broch M, Vendrell J, Ricart W, Richart C & Fernandez-Real JM. Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects. Diabetes Care 2007 30 1802-1806. (doi:10.2337/dc06- 2034)
12. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, Minnemann T, Shulman GI & Kahn BB. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 2001 409 729-733. (doi:10.1038/35055575)
13. Gnudi L, Shepherd PR & Kahn BB. Over-expression of GLUT4 selectively in adipose tissue in transgenic mice: implications for nutrient partitioning. Proceedings of the Nutrition Society 1996 55 191-199. (doi:10.1079/PNS19960020)
14. Flower DR. The lipocalin protein family: structure and function. Biochemical Journal 1996 318 1-14. (Pubitemid 26283618)
15. Meigs JB, Panhuysen CI, Myers RH, Wilson PW & Cupples LA. A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: the Framingham Offspring Study. Diabetes 2002 51 833-840. (doi:10.2337/diabetes.51.3.833)
16. Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL, Leach RJ, O'Connell P & Stern MP. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. American Journal of Human Genetics 1999 64 1127-1140. (doi:10.1086/302316)
17. Colantuoni V, Romano V, Bensi G, Santoro C, Costanzo F, Raugei G & Cortese R. Cloning and sequencing of a full length cDNA coding for human retinol-binding protein. Nucleic Acids Research 1983 11 7769-7776. (doi:10.1093/nar/11.22.7769)
18. Jaconi S, Rose K, Hughes GJ, Saurat JH & Siegenthaler G. Characterization of two post-translationally processed forms of human serum retinol-binding protein: altered ratios in chronic renal failure. Journal of Lipid Research 1995 36 1247-1253.
19. Tsutsumi C, Okuno M, Tannous L, Piantedosi R, Allan M, Goodman DS & Blaner WS. Retinoids and retinoid-binding protein expression in rat adipocytes. Journal of Biological Chemistry 1992 267 1805-1810.
20. Zovich DC, Orologa A, Okuno M, Kong LW, Talmage DA, Piantedosi R, Goodman DS & Blaner WS. Differentiation-dependent expression of retinoid-binding proteins in BFC-1 beta adipocytes. Journal of Biological Chemistry 1992 267 13884-13889.
21. Newcomer ME & Ong DE. Plasma retinol binding protein: structure and function of the prototypic lipocalin. Biochimica et Biophysica Acta 2000 1482 57-64. (doi:10.1016/S0167-4838(00)00150-3)
22. Erikstrup C, Mortensen OH, Nielsen AR, Fischer CP, Plomgaard P, Petersen AM, Krogh-Madsen R, Lindegaard B, Erhardt JG, Ullum H, Benn CS & Pedersen BK. RBP-to-retinol ratio, but not total RBP, is elevated in patients with type 2 diabetes. Diabetes, Obesity&Metabolism 2009 11 204-212. (doi:10.1111/j.1463-1326.2008.00901.x)
23. Goodman AB. Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset Alzheimer disease. Journal of Cellular Physiology 2006 209 598-603. (doi:10.1002/jcp.20784)
24. Mody N, Graham TE, Tsuji Y, Yang Q & Kahn BB. Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice. American Journal of Physiology. Endocrinology and Metabolism 2008 294 E785-E793. (doi:10.1152/ajpendo.00521.2007)
25. Frey SK, Spranger J, Henze A, Pfeiffer AF, Schweigert FJ & Raila J. Factors that influence retinol-binding protein 4-transthyretin interaction are not altered in overweight subjects and overweight subjects with type 2 diabetes mellitus. Metabolism 2009 58 1386-1392. (doi:10.1016/j.metabol.2009.05.003)
26. Fernandez-Real JM, Moreno JM & Ricart W. Circulating retinol-binding protein-4 concentration might reflect insulin resistance-associated iron overload. Diabetes 2008 57 1918-1925. (doi:10. 2337/db08-0041)
27. Sivaprasadarao A & Findlay JB. The interaction of retinol-binding protein with its plasma-membrane receptor. Biochemical Journal 1988 255 561-569.
28. Matarese V & Lodish HF. Specific uptake of retinol-binding protein by variant F9 cell lines. Journal of Biological Chemistry 1993 268 18859-18865. (Pubitemid 23273832)
29. Kawaguchi R, Yu J, Honda J, Hu J, Whitelegge J, Ping P, Wiita P, Bok D & Sun H. A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science 2007 315 820-825. (doi:10.1126/science.1136244)
30. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB Journal 1996 10 940-954. (Pubitemid 26285969)
31. Nair AK, Sugunan D, Kumar H & Anilkumar G. Case-control analysis of SNPs in GLUT4, RBP4 and STRA6: association of SNPs in STRA6 with type 2 diabetes in a South Indian population. PLoS ONE 2010 5 e11444. (doi:10.1371/journal. pone.0011444)
32. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U & Kahn BB. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. New England Journal of Medicine 2006 354 2552-2563. (doi:10.1056/NEJMoa054862)
33. Kovacs P, Geyer M, Berndt J, Kloting N, Graham TE, Bottcher Y, Enigk B, Tonjes A, Schleinitz D, Schon MR, Kahn BB, Bluher M & Stumvoll M. Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression. Diabetes 2007 56 3095-3100. (doi:10. 2337/db06-1647)
34. Munkhtulga L, Nagashima S, Nakayama K, Utsumi N, Yanagisawa Y, Gotoh T, Omi T, Kumada M, Zolzaya K, Lkhagvasuren T, Kagawa Y, Fujiwara H, Hosoya Y, Hyodo M, Horie H, Kojima M, Ishibashi S & Iwamoto S. Regulatory SNP in the RBP4 gene modified the expression in adipocytes and associated with BMI. Obesity 2010 18 1006-1014. (doi:10. 1038/oby.2009.358)
35. Cho YM, Youn BS, Lee H, Lee N, Min SS, Kwak SH, Lee HK & Park KS. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 2006 29 2457-2461. (doi:10. 2337/dc06-0360)
36. Gavi S, Stuart LM, Kelly P, Melendez MM, Mynarcik DC, Gelato MC & McNurlan MA. Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2007 92 1886-1890. (doi:10.1210/jc.2006- 1815)
37. Jia W, Wu H, Bao Y, Wang C, Lu J, Zhu J & Xiang K. Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2007 92 3224-3229. (doi:10. 1210/jc.2007-0209)
38. Lee JW, Im JA, Lee HR, Shim JY, Youn BS & Lee DC. Visceral adiposity is associated with serum retinol binding protein-4 levels in healthy women. Obesity 2007 15 2225-2232. (doi:10.1038/ oby.2007.264)
39. Kelly KR, Kashyap SR, O'Leary VB, Major J, Schauer PR & Kirwan JP. Retinol-binding protein 4 (RBP4) protein expression is increased in omental adipose tissue of severely obese patients. Obesity 2010 18 663-666. (doi:10.1038/oby.2009.328)
40. Kloting N, Graham TE, Berndt J, Kralisch S, Kovacs P, Wason CJ, Fasshauer M, Schon MR, Stumvoll M, BluherM& Kahn BB. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metabolism 2007 6 79-87. (doi:10.1016/j.cmet. 2007.06.002)
41. Hermsdorff HH, Zulet MA, Puchau B & Martinez JA. Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults. Inflammation 2010 34 161-170. (doi:10.1007/s10753-010- 9219-y)
42. Haider DG, Schindler K, Prager G, Bohdjalian A, Luger A,WolztM& LudvikB. Serumretinol-binding protein4is reduced afterweight loss in morbidly obese subjects. Journal of Clinical Endocrinology and Metabolism 2007 92 1168-1171. (doi:10.1210/jc.2006-1839)
43. Lee JW, Lee HR, Shim JY, Im JA & Lee DC. Abdominal visceral fat reduction is associated with favorable changes of serum retinol binding protein-4 in nondiabetic subjects. Endocrine Journal 2008 55 811-818. (doi:10.1507/endocrj.K08E-030)
44. Vitkova M, Klimcakova E, Kovacikova M, Valle C, Moro C, Polak J, Hanacek J, Capel F, Viguerie N, Richterova B, Bajzova M, Hejnova J, Stich V & Langin D. Plasma levels and adipose tissue messenger ribonucleic acid expression of retinol-binding protein 4 are reduced during calorie restriction in obese subjects but are not related to diet-induced changes in insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 2007 92 2330-2335. (doi:10.1210/jc.2006-2668)
45. Basualdo CG,Wein EE & Basu TK. Vitamin A (retinol) status of first nation adults with non-insulin-dependent diabetes mellitus. Journal of the American College of Nutrition 1997 16 39-45. (Pubitemid 27073673)
46. AbahusainMA,Wright J, Dickerson JW& de Vol EB. Retinol, alpha-tocopherol and carotenoids in diabetes. European Journal of Clinical Nutrition 1999 53 630-635. (doi:10.1038/sj.ejcn.1600825)
47. Kloting N, Fasshauer M, Dietrich A, Kovacs P, Schon MR, Kern M, Stumvoll M & Bluher M. Insulin-sensitive obesity. American Journal of Physiology. Endocrinology and Metabolism 2010 299 E506-E515. (doi:10.1152/ajpendo.00586. 2009)
48. Craig RL, Chu WS & Elbein SC. Retinol binding protein 4 as a candidate gene for type 2 diabetes and prediabetic intermediate traits. Molecular Genetics and Metabolism 2007 90 338-344. (doi:10.1016/j.ymgme.2006.11. 003)
49. Munkhtulga L, Nakayama K, Utsumi N, Yanagisawa Y, Gotoh T, Omi T, Kumada M, Erdenebulgan B, Zolzaya K, Lkhagvasuren T & Iwamoto S. Identification of a regulatory SNP in the retinol binding protein 4 gene associated with type 2 diabetes in Mongolia. Human Genetics 2007 120 879-888. (doi:10.1007/ s00439-006-0264-4)
50. Ku YH, Han KA, Ahn H, Kwon H, Koo BK, Kim HC & Min KW. Resistance exercise did not alter intramuscular adipose tissue but reduced retinol-binding protein-4 concentration in individuals with type 2 diabetes mellitus. Journal of International Medical Research 2010 38 782-791.
51. Qi Q, Yu Z, Ye X, Zhao F, Huang P, Hu FB, Franco OH,Wang J, Li H, Liu Y & Lin X. Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. Journal of Clinical Endocrinology and Metabolism 2007 92 4827-4834. (doi:10.1210/jc.2007-1219)
52. Makino S, Fujiwara M, Suzukawa K, Handa H, Fujie T, Ohtaka Y, Komatsu Y, Aoki Y, Maruyama H, Terada Y, Hashimoto K & Sugimoto T. Visceral obesity is associated with the metabolic syndrome and elevated plasma retinol binding protein-4 level in obstructive sleep apnea syndrome. Hormone and Metabolic Research 2009 41 221-226. (doi:10.1055/s-0028-1100411)
53. Lim S, Yoon JW, Choi SH, Park YJ, Lee JJ, Park JH, Lee SB, Kim KW, Lim JY, Kim YB, Park KS, Lee HK, Cho SI & Jang HC. Combined impact of adiponectin and retinol-binding protein 4 on metabolic syndrome in elderly people: the Korean Longitudinal Study on Health and Aging. Obesity 2010 18 826-832. (doi:10.1038/oby. 2009.232)
54. Wu Y, Li H, Loos RJ, Qi Q, Hu FB, Liu Y & Lin X. RBP4 variants are significantly associated with plasma RBP4 levels and hypertrigly-ceridemia risk in Chinese Hans. Journal of Lipid Research 2009 50 1479-1486. (doi:10.1194/jlr.P900014-JLR200)
55. Bobbert T, Raila J, Schwarz F, Mai K, Henze A, Pfeiffer AF, Schweigert FJ & Spranger J. Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima media thickness. Atherosclerosis 2010 213 549-551. (doi:10.1016/j. atherosclerosis.2010.07.063)
56. Sasaki M, Otani T, Kawakami M & Ishikawa SE. Elevation of plasma retinol-binding protein 4 and reduction of plasma adiponectin in subjects with cerebral infarction. Metabolism 2010 59 527-532. (doi:10.1016/j.metabol.2009.08. 015)
57. Ingelsson E, Sundstrom J, Melhus H, Michaelsson K, Berne C, Vasan RS, Riserus U, Blomhoff R, Lind L & Arnlov J. Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly. Atherosclerosis 2009 206 239-244. (doi:10.1016/j.atherosclerosis.2009. 02.029)
58. Mallat Z, Simon T, Benessiano J, Clement K, Taleb S,Wareham NJ, Luben R, Khaw KT, Tedgui A & Boekholdt SM. Retinol-binding protein 4 and prediction of incident coronary events in healthy men and women. Journal of Clinical Endocrinology and Metabolism 2009 94 255-260. (doi:10.1210/jc.2008-0253)
59. Choi KM, Yannakoulia M, Park MS, Cho GJ, Kim JH, Lee SH, Hwang TG, Yang SJ, Kim TN, Yoo HJ, Baik SH, Kim SM & Mantzoros CS. Serum adipocyte fatty acid-binding protein, retinol-binding protein 4, and adiponectin concentrations in relation to the development of the metabolic syndrome in Korean boys: a 3-y prospective cohort study. American Journal of Clinical Nutrition 2011 9 19-26. (doi:10.3945/ajcn.2010.29667)
60. Aust G, Uptaite-Patapoviene M, Scholz M, Richter O, Rohm S & BluherM. Circulating Nampt and RBP4 levels in patients with carotid stenosis undergoing carotid endarterectomy (CEA). Clinica Chimica Acta 2011 412 1195-1200. (doi:10.1016/j.cca.2011.03.008)
61. Aeberli I, Biebinger R, Lehmann R, L'allemand D, Spinas GA & Zimmermann MB. Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. Journal of Clinical Endocrinology and Metabolism 2007 92 4359-4365. (doi:10. 1210/jc.2007-0468)
62. Balagopal P, Graham TE, Kahn BB, Altomare A, Funanage V & George D. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with sub-clinical inflammation. Journal of Clinical Endocrinology and Metabolism 2007 92 1971-1974. (doi:10.1210/jc.2006- 2712)
63. Reinehr T, Stoffel-Wagner B & Roth CL. Retinol-binding protein 4 and its relation to insulin resistance in obese children before and after weight loss. Journal of Clinical Endocrinology and Metabolism 2008 93 2287-2293. (doi:10.1210/jc.2007-2745)
64. Yeste D, Vendrell J, Tomasini R, Gallart LL, Clemente M, Simon I, Albisu M, Gussinye M, Audi L & Carrascosa A. Retinol-binding protein 4 levels in obese children and adolescents with glucose intolerance. Hormone Research in Pediatrics 2010 73 335-340. (doi:10.1159/000308165)
65. Kim IK, Lee HJ, Kang JH & Song J. Relationship of serum retinol-binding protein 4 with weight status and lipid profile among Korean children and adults. European Journal of Clinical Nutrition 2011 65 226-233. (doi:10.1038/ejcn.2010.251)
66. Friebe D, Neef M, Erbs S, Dittrich K, Kratzsch J, Kovacs P, Bluher M, KiessW& Korner A. Retinol binding protein 4 (RBP4) is primarily associated with adipose tissue mass in children. International Journal of Pediatric Obesity 2010 6 e346-e352.
67. LeeDC, Lee JW&Im JA.Association of serumretinol binding protein 4 and insulin resistance in apparently healthy adolescents. Metabolism 2007 56 327-331. (doi:10.1016/j.metabol.2006.10.011)
68. Santoro N, Perrone L, Cirillo G, Brienza C, Grandone A, Cresta N & Miraglia del GE. Variations of retinol binding protein 4 levels are not associated with changes in insulin resistance during puberty. Journal of Endocrinological Investigation 2009 32 411-414.
69. Goodman E, Graham TE, Dolan LM, Daniels SR, Goodman ER & Kahn BB. The relationship of retinol binding protein 4 to changes in insulin resistance and cardiometabolic risk in overweight black adolescents. Journal of Pediatrics 2009 154 67-73. (doi:10.1016/ j.jpeds.2008.07.018)
70. Giacomozzi C, Ghirri P, Lapolla R, Bartoli A, Scire G, Serino L, Germani D, Boldrini A & Cianfarani S. Retinol-binding protein 4 in neonates born small for gestational age. Journal of Endocrinological Investigation 2010 33 218-221.
71. Kanaka-Gantenbein C, Margeli A, Pervanidou P, Sakka S, Mastorakos G, Chrousos GP & Papassotiriou I. Retinol-binding protein 4 and lipocalin-2 in childhood and adolescent obesity: when children are not just "small adults". Clinical Chemistry 2008 54 1176-1182. (doi:10.1373/clinchem.2007. 099002)
72. Ulgen F, Herder C, Kuhn MC, Willenberg HS, Schott M, Scherbaum WA & Schinner S. Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients. Archives of Physiology and Biochemistry 2010 116 57-62. (doi:10.3109/13813451003631421)
73. Kos K, Wong S, Tan B, Kerrigan D, Randeva H, Pinkney J & Wilding J. Human RBP4 adipose tissue expression is gender specific and influenced by leptin. Clinical Endocrinology 2010 74 197-205. (doi:10.1111/j.1365-2265.2010. 03892.x)
74. Promintzer M, Krebs M, Todoric J, Luger A, Bischof MG, Nowotny P, Wagner O, Esterbauer H & Anderwald C. Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor. Journal of Clinical Endocrinology and Metabolism 2007 92 4306-4312. (doi:10.1210/jc.2006-2522)
75. von Eynatten M, Lepper PM, Liu D, Lang K, Baumann M, Nawroth PP, Bierhaus A, Dugi KA, Heemann U, Allolio B & Humpert PM. Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia 2007 50 1930-1937. (doi:10.1007/s00125-007- 0743-8)
76. Ribel-Madsen R, Friedrichsen M, Vaag A & Poulsen P. Retinol-binding protein 4 in twins: regulatory mechanisms and impact of circulating and tissue expression levels on insulin secretion and action. Diabetes 2009 58 54-60. (doi:10.2337/db08-1019)
77. Chavez AO, Coletta DK, Kamath S, Cromack DT, Monroy A, Folli F, DeFronzo RA & Tripathy D. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans. American Journal of Physiology. Endocrinology and Metabolism 2009 296 E758-E764. (doi:10.1152/ajpendo.90737.2008)
78. Henze A, Frey SK, Raila J, Tepel M, Scholze A, Pfeiffer AF, Weickert MO, Spranger J & Schweigert FJ. Evidence that kidney function but not type 2 diabetes determines retinol-binding protein 4 serum levels. Diabetes 2008 57 3323-3326. (doi:10. 2337/db08-0866)
79. Murata M, Saito T, Otani T, Sasaki M, Ikoma A, Toyoshima H, Kawakami M & Ishikawa SE. An increase in serum retinol-binding protein 4 inthe type 2diabetic subjects with nephropathy. Endocrine Journal 2009 56 287-294. (doi:10.1507/endocrj.K08E-242)
80. Akbay E, Muslu N, Nayir E, Ozhan O & Kiykim A. Serum retinol binding protein 4 level is related with renal functions in type 2 diabetes. Journal of Endocrinological Investigation 201033725-729.
81. Ziegelmeier M, Bachmann A, Seeger J, Lossner U, Kratzsch J, Bluher M, Stumvoll M & Fasshauer M. Serum levels of adipokine retinol-binding protein-4 in relation to renal function. Diabetes Care 2007 30 2588-2592. (doi:10.2337/dc07-0275)
82. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T & Matsuzawa Y. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002 51 2734-2741. (doi:10.2337/ diabetes.51.9.2734)
83. Wabitsch M, Blum WF, Muche R, Braun M, Hube F, Rascher W, Heinze E, Teller W & Hauner H. Contribution of androgens to the gender difference in leptin production in obese children and adolescents. Journal of Clinical Investigation 1997 100 808-813. (doi:10.1172/JCI119595)
84. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Schleicher E, Fritsche A & Haring HU. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Diabetes Care 2007 30 1173-1178. (doi:10.2337/dc06-2342)
85. Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y & Inukai T. Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. Journal of Clinical Endocrinology and Metabolism 2007 92 2712-2719. (doi:10.1210/jc.2006-1249)
86. An C, Wang H, Liu X, Li Y, Su Y, Gao X & Jiang W. Serum retinol-binding protein 4 is elevated and positively associated with insulin resistance in postmenopausal women. Endocrine Journal 2009 56 987-996. (doi:10.1507/endocrj.K09E-096)
87. Suh JB, Kim SM, Cho GJ, Choi KM, Han JH & Taek GH. Elevated serum retinol-binding protein 4 is associated with insulin resistance in older women. Metabolism 2010 59 118-122. (doi:10.1016/j.metabol.2009.06.025)
88. Weiping L, Qingfeng C, Shikun M, Xiurong L, Hua Q, Xiaoshu B, Suhua Z & Qifu L. Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome. Endocrine 2006 30 283-287. (doi:10.1007/s12020- 006-0006-3)
89. Aigner E, Bachofner N, Klein K, De Geyter C, Hohla F, Patsch W & Datz C. Retinol-binding protein 4 in polycystic ovary syndrome-association with steroid hormones and response to pioglitazone treatment. Journal of Clinical Endocrinology and Metabolism 2009 94 1229-1235. (doi:10.1210/jc.2008-2156)
90. Tan BK, Chen J, Lehnert H, Kennedy R & Randeva HS. Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids. Journal of Clinical Endocrinology and Metabolism 2007 92 2764-2772. (doi:10.1210/jc.2007- 0091)
91. Ost A, Danielsson A, Liden M, Eriksson U, NystromFH & Stralfors P. Retinol-binding protein-4 attenuates insulin-induced phosphorylation of IRS1 and ERK1/2 in primary human adipocytes. FASEB Journal 2007 21 3696-3704. (doi:10.1096/fj.07-8173com)
92. Sell H & Eckel J. Regulation of retinol binding protein 4 production in primary human adipocytes by adiponectin, troglitazone and TNF-alpha. Diabetologia 2007 50 2221-2223. (doi:10.1007/ s00125-007-0764-3)
93. Bajzova M, Kovacikova M, Vitkova M, Klimcakova E, Polak J, Kovacova Z, Viguerie N, Vedral T, Mikulasek L, Sramkova P, Srp A, Hejnova J, Langin D & Stich V. Retinol-binding protein 4 expression in visceral and subcutaneous fat in human obesity. Physiological Research 2008 57 927-934.